Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TIAPROFENIC ACID | 300MG | TABLET | Resolved | 2020-01-24 | 2020-02-13 | 104350 |
TEVA-TIAPROFENIC ACID | 200MG | TABLET | Resolved | 2021-11-18 | 2022-02-17 | 149612 |
TEVA-TIAPROFENIC ACID | 200MG | TABLET | Resolved | 2023-07-20 | 2023-10-05 | 199360 |
TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2022-07-25 | 2022-12-08 | 165447 |
TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2023-06-08 | 2023-06-21 | 194160 |
TEVA-TOBRAMYCIN | 60MG | SOLUTION | Actual shortage | 2024-05-09 | 2025-04-24 | 227495 |
TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2020-02-21 | 2020-03-26 | 106942 |
TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2021-10-14 | 2021-12-17 | 147231 |
TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2020-01-17 | 2020-02-07 | 103593 |
TEVA-TOBRAMYCIN | 60MG | SOLUTION | Resolved | 2017-05-23 | 2018-07-30 | 10911 |
TEVA-TOLTERODINE | 1MG | TABLET | Resolved | 2024-03-21 | 2024-03-21 | 222947 |
TEVA-TOLTERODINE | 1MG | TABLET | Actual shortage | 2023-10-05 | 2024-01-08 | 206410 |
TEVA-TOLTERODINE | 2MG | TABLET | Actual shortage | 2023-10-05 | 2024-01-08 | 206413 |
TEVA-TOLTERODINE | 1MG | TABLET | Resolved | 2019-08-22 | 2021-08-05 | 92218 |
TEVA-TOLTERODINE | 1MG | TABLET | Resolved | 2019-09-05 | 2021-07-22 | 93152 |
TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-01-30 | 2020-03-19 | 104902 |
TEVA-TOLTERODINE LA | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-03-18 | 2021-04-29 | 135952 |
TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-04-27 | 2023-06-27 | 190713 |
TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-09-24 | 2020-11-12 | 125007 |
TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-11-27 | 2020-12-17 | 129050 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
TEVA-AZITHROMYCIN | 250MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255821 |
TEVA-CARBAMAZEPINE | 200MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14052 |
TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
TEVA-CEPHALEXIN | 250MG | TABLET | Discontinued | 2020-10-08 | 2020-10-09 | 125982 |
TEVA-CIPROFLOXACIN | 500MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14049 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
TEVA-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117529 |
TEVA-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117526 |
TEVA-CLOBETASOL | 0.05% | LOTION | Discontinued | 2025-04-25 | 2025-04-25 | 255815 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |